News
Two Humboldt Fellows at HITS
Since 2012, HITS has been the host for eight fellows of the Humboldt foundation. This year, the institute was glad to welcome …
Wade and Nunes Alves on boards of the JCIM
Recently, HITS researchers from the Molecular and Cellular Modeling (MCM) group have been appointed to boards of the Journal of Chemical …
New & Special: The state-of-the-art of ‘Molecular Modeling in Drug Design’
New Special Issue in the journal ‘Molecules’ out on the state-of-the-art of ‘Molecular Modeling in Drug Design’ guest edited by Rebecca …
The need for speed: Why malaria parasites are faster than human immune cells
Elementary cytoskeleton protein is different in parasites and represents a starting point for a possible new therapy against malaria infections. Researchers …
New computational method for drug discovery
HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover …
Accelerated reactions in condensed bio-matter?
HITS researcher Dr. Kashif Sadiq explores ribonucleoprotein granules, a condensed form of bio-matter found inside cells. He investigates whether the rate …
EuroNeurotrophin project starts
14 Early Stage Researchers to be trained in a European training network for the discovery of small molecule neurotrophin mimetics as candidate …
A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The …
powered by Borlabs Cookie